Reimagining Medicines Optimisation: A Call to Action for Addressing Health Inequalities
Petersfield, Hampshire, 30 October 2024 – Aspire Pharma Ltd in 2023 spearheaded an important initiative called Medicines Optimisation Centricity and initiated a White Paper published in May 2023 via Health Service Journal (HSJ), which urged…
Acquisition Strengthens Aspire Pharma’s Strategic Portfolio
Petersfield, Hampshire, 4 October 2024: Aspire Pharma Limited, a high growth UK-based specialty niche generics business, announces the further strengthening of its product portfolio through the acquisition of all assets from Canute Pharma Limited.
The…
Medicines Optimisation Centricity – addressing Access & Choice to Medicine Inequalities and Inequities
Petersfield, Hampshire, 01 October 2024, Aspire Pharma Ltd has initiated and funded a new report on improving access and choice to medicines by bringing the patient into the centre of the decision-making process; which follows the publication…